ORDER A TEST Log In Contact Us

FOUNDATION MODELS

Tempus is your end-to-end partner to accelerate your AI strategy.
Contact us

Leverage our multimodal data and foundation models, deployed at scale.

One of the largest multimodal datasets in the world

~50 million unique cases across therapeutic areas, many with sequencing, imaging, and clinical histories

State-of-the-art foundation models and AI technology

Scientifically proven, multimodal foundation models and off-the-shelf tools accelerate and de-risk your AI development

Proven expertise developing clinical-grade AI

Bring AI models from initial proof-of-concept to robust, validated, and documented products suitable for the clinic

Regulatory excellence and track record

Multiple FDA authorizations across software (SaMD) and traditional diagnostics; dedicated regulatory team with extensive FDA and international expertise

Extensive deployment network and patient footprint

We operate at scale, reaching ~50% of US oncologists, with global infrastructure in place for broad AI deployment

image description

State of the Art Foundation Models

We pioneered the Virchow and PRISM models, combining pathology images and clinical notes, setting the benchmark for foundation models in computational pathology.

image description

Multimodal Foundation Model Expansion

We are building a unified foundation model that combines our data across modalities to develop a comprehensive understanding of the complexity of disease, beginning 
with oncology.

image description

Future Vision for Foundation Models

As our dataset continues to scale, and we incorporate new data modalities, these modalities will be integrated into our foundation models, broadening capabilities and expanding to new disease areas.

image description
image description

Navigate the regulatory landscape with our expertise across software and traditional diagnostics

From AI-powered pathology to companion diagnostics, we provide end-to-end guidance to navigate submission and launch.

Read more about our IVDR Approval for Paige Prostate

  • SOFTWARE CLEARANCES

    • Secured the first and only FDA de novo clearance for an AI-enabled pathology product, Paige Prostate Detect
    • Gained multiple 510(k) clearances for AI-enabled algorithms, including ECG-AF and ECG-Low EF
    • Earned two additional FDA Breakthrough Device Designations for Paige Breast Lymph Node and Paige PanCancer Detect
    • Holds nine FDA clearances for its Pixel cloud-hosted viewer and applications
    • Received 510(k) clearance for the FullFocus viewer, compatible with three major whole slide image scanners
    • Obtained IVDR approval and 12 CE-IVD/UKCA marks covering 18 algorithms

  • TRADITIONAL DIAGNOSTICS

    • Received FDA approval for its xT CDx assay and 510(k) clearance for its xR IVD assay
    • Regulatory affairs team of 10+ professionals with extensive FDA experience
image description

Once AI-enabled diagnostics are developed, Tempus enables their deployment at scale

  • ~1M

    tests run annually on our labs

  • ~5K+

    connected healthcare institutions

  • ~65%

    of academic medical systems in the US are connected to Tempus

  • ~50%

    of oncologists in the U.S

image description
image description

We offer flexible frameworks to align our AI capabilities with your needs

ACCESS OUR TECHNOLOGY OFF-THE-SHELF

Enable your internal AI development

  • License our pathology and multimodal foundation models to accelerate your development
  • Access off-the-shelf AI tools, such as Paige Predict for biomarker prediction across 505 genes
PARTNER WITH US, FROM POC THROUGH COMMERCIALIZATION

Enable your internal AI development

  • Work together to build an new AI application or novel biomarker for your therapy
  • Validate, deploy, and navigate complex regulatory submissions with our expertise
  • Scale and drive clinical adoption through our extensive deployment network

Webinar Replay

Unlocking foundation models: Our experience from proof of concept to deployment at scale

An executive discussion on leveraging multi-modal foundation models to accelerate your drug development journey

Watch it now
image description

Hear from our experts

  • image description

    From proof of concept to clinical deployment: How foundation models are accelerating drug development

    Tempus leaders discuss the practical application of multimodal foundation models, from de-risking programs and uncovering novel biomarkers to deploying AI-driven insights at the point of care.

    LEARN MORE
  • image description

    From image to insight: How Tempus is leveraging AI to advance biomarker screening at scale

    By leveraging Paige Predict to screen for genomic and phenotypic biomarkers, clinicians and researchers have rapid access to valuable information to prioritize testing and pre-screen patients at scale.

    LEARN MORE
  • image description

    Solving cancer’s tissue scarcity problem: How Tempus uses AI models in pathology to transform tissue analysis

    Tempus AI research demonstrates how AI can analyze digitized pathology images to predict tissue sample viability for genomic testing, a task that pathologists struggle to perform consistently.

    LEARN MORE

Featured News

view all news
  • UPCOMING WEBINAR:

    Tempus Announces the Acquisition of Paige

    Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated

    Read more
  • UPCOMING WEBINAR:

    Tempus Announces the Launch of Paige Predict

    Read more

Our Research

  • UPCOMING WEBINAR:

    Using Artificial Intelligence To Prioritize Pathology Samples: Report of a Test Drive

    Learn more
  • UPCOMING WEBINAR:

    Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases

    Learn more
  • UPCOMING WEBINAR:

    A Foundation Model for Clinical-Grade Computational Pathology and Rare Cancers Detection

    Learn more
  • UPCOMING WEBINAR:

    Clinical Validation of Artificial Intelligence–Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection

    Learn more
  • UPCOMING WEBINAR:

    Artificial intelligence–assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies

    Learn more
  • UPCOMING WEBINAR:

    An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy

    Learn more
  • UPCOMING WEBINAR:

    Independent real-world application of a clinical-grade automated prostate cancer detection system

    Learn more
  • UPCOMING WEBINAR:

    Clinical-grade computational pathology using weakly supervised deep learning on whole slide images

    Learn more

Partner with Tempus to accelerate AI in drug development

Let’s build the future of precision medicine together. Contact our team to learn how our AI development services can accelerate your pipeline.